Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 286, Issue 6 30-6, 2004, Pages

  Ishizaka, Akitoshi ^a   Matsuda, Tomoyuki ^b   Albertine, Kurt H ^d   Koh, Hidefumi ^a   Tasaka, Sadatomo ^a   Hasegawa, Naoki ^a   Kohno, Nobuoki ^c   Kotani, Toru ^a   Morisaki, Hiroshi ^a   Takeda, Junzo ^a   Nakamura, Morio ^e   Fang, Xiaohui ^f   Martin, Thomas R ^e   Matthay, Michael A ^f   Hashimoto, Satoru ^b  

^a KEIO UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alveolar type II cell; Microsampling; Pulmonary edema

Indexed keywords

ALBUMIN; CELL MARKER; KL 6 PROTEIN; MUCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL TYPE 2; LUNG EDEMA; LUNG FLUID; LUNG INJURY; MALE; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RESPIRATORY DISTRESS SYNDROME;

ADULT; AGED; ANTIGENS; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; EPITHELIAL CELLS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; MUCINS; PULMONARY ALVEOLI; PULMONARY EDEMA; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY MUCOSA; SURVIVAL RATE;

EID: 2442676627     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00420.2002     Document Type: Article

References (32)

1. Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, Zimmerman GA, Matthay MA, and Ware LB. Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 161: 1783-1796, 2002.
2. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, and Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824, 1994.
3. Bersten AD, Hunt T, Nicholas TE, and Doyle IR. Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute respiratory failure. Am J Respir Crit Care Med 164: 648-652, 2001.
4. Bingle L, Bull TB, Fox B, Guz A, Richards RJ, and Tetley TD. Type II pneumocytes in mixed cell culture of human lung: a light and electron microscopic study. Environ Health Perspect 85: 71-80, 1990.
5. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, and Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655, 1992.
6. Brigham KL. Lung edema due to increased vascular permeability. In: Lung Water and Solute Exchange, edited by Staub NC. New York: Dekker, 1978, p. 235-276.
7. Chesnutt AN, Matthay MA, Tibayan FA, and Clark JG. Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. Am J Respir Crit Care Med 156: 840-845, 1997.
8. Clark JG, Milberg JA, Steinberg KP, and Hudson LD. Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 122: 17-23, 1995.
9. Cunningham AC, Milne DS, Wilkes J, Dark JH, Tetley TD, and Kirby JA. Constitutive expression of MHC and adhesion molecules by alveolar epithelial cells (type II pneumocytes) isolated from human lung and comparison with immunocytochemical findings. J Cell Sci 107: 443-449, 1994.
10. Edelson JD, Shannon JM, and Mason RJ. Effects of two extracellular matrices on morphologic and biochemical properties of human type II cells in vitro. Am Rev Respir Dis 140: 1398-1404, 1989.
11. Elbert KJ, Schafer UF, Schafers HJ, Kim KJ, Lee VH, and Lehr CM. Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies. Pharm Res 16: 601-608, 1999.
12. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y, Nagae H, Hudson LD, and Martin TR. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 160: 1843-1850, 1999.
13. Hilkens J, Ligtenberg MJ, Vos HL, and Litvinov SV. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci 17: 359-363, 1992.
14. Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, and Hiwada K. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 17: 501-507, 1997.
15. Imaizumi T, Albertine KH, Jicha DL, McIntyre TM, Prescott SM, and Zimmerman GA. Human endothelial cells synthesize ENA-78: relationship to IL-8 and to signaling of PMN adhesion. Am J Respir Cell Mol Biol 17: 181-192, 1997.
16. Ishizaka A, Watanabe M, Yamashita T, Ogawa Y, Koh H, Hasegawa N, Nakamura H, Asano K, Yamaguchi K, Kotani M, Kotani T, Morisaki H, Takeda J, Kobayashi K, and Ogawa S. New bronchoscopic microsample probe to measure the biochemical constituents in epithelial lining fluid of patients with acute respiratory distress syndrome. Crit Care Med 29: 896-898, 2001.
17. Kohler G and Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495-497, 1975.
18. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, and Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 18: 203-216, 1988.
19. Kohno N, Awaya Y, Oyama T, Yamakido M, Akiyama M, Inoue Y, Yokoyama A, Hamada H, Fujioka S, and Hiwada K. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 148: 637-642, 1993.
20. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, and Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 96: 68-73, 1989.
21. Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW, Martin TR, and Wiener-Kronish JP. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest 104: 743-750, 1999.
22. Matthay MA and Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 142: 1250-1257, 1990.
23. Modelska K, Pittet JF, Folkesson HG, Courtney Broaddus V, and Matthay MA. Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits. Am J Respir Crit Care Med 160: 1450-1456, 1999.
24. Murray JF, Matthay MA, Luce JM, and Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 138: 720-723, 1988.
25. Pittet JF, Lu LN, Morris DG, Modelska K, Welch WJ, Carey HV, Roux J, and Matthay MA. Reactive nitrogen species inhibit alveolar epithelial fluid transport after hemorrhagic shock in rats. J Immunol 166: 6301-6310, 2001.
26. Pittet JF, Mackersie RC, Martin TR, and Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 155: 1187-1205, 1997.
27. Pugin J, Verghese G, Widmer MC, and Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 27: 304-312, 1999.
28. Stahel RA, Gilks WR, Lehmann HP, and Schenker T. Third international workshop on lung tumor and differentiation antigens: overview of the results of the central data analysis. Int J Cancer Suppl 8: 6-26, 1994.
29. Steinberg KP, Mitchell DR, Maunder RJ, Milberg JA, Whitcomb ME, and Hudson LD. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am Rev Respir Dis 148: 556-561, 1993.
30. Ware LB and Matthay MA. Medical progress: the acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
31. Ware LB, Wang Y, Fang X, Warnock M, Sakuma T, Hall TS, and Matthay M. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 360: 619-620, 2002.
32. Wiener-Kronish JP, Albertine KH, and Matthay MA. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest 88: 864-875, 1991.